T. Rowe Price Associates’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.68B | Buy |
|
|||||
|
2025
Q1 | $1.51B | Sell |
|
|||||
|
2024
Q4 | $1.81B | Sell |
|
|||||
|
2024
Q3 | $2.03B | Sell |
|
|||||
|
2024
Q2 | $1.88B | Buy |
|
|||||
|
2024
Q1 | $1.96B | Buy |
|
|||||
|
2023
Q4 | $1.46B | Sell |
|
|||||
|
2023
Q3 | $1.91B | Sell |
|
|||||
|
2023
Q2 | $1.77B | Sell |
|
|||||
|
2023
Q1 | $2.8B | Sell |
|
|||||
|
2022
Q4 | $3.3B | Sell |
|
|||||
|
2022
Q3 | $3.29B | Sell |
|
|||||
|
2022
Q2 | $4.72B | Sell |
|
|||||
|
2022
Q1 | $5.95B | Buy |
|
|||||
|
2021
Q4 | $4.41B | Buy |
|
|||||
|
2021
Q3 | $2.83B | Sell |
|
|||||
|
2021
Q2 | $3.27B | Sell |
|
|||||
|
2021
Q1 | $3.49B | Sell |
|
|||||
|
2020
Q4 | $3.48B | Sell |
|
|||||
|
2020
Q3 | $2.87B | Sell |
|
|||||
|
2020
Q2 | $4.1B | Sell |
|
|||||
|
2020
Q1 | $3.27B | Buy |
|
|||||
|
2019
Q4 | $2.49B | Buy |
|
|||||
|
2019
Q3 | $1.5B | Buy |
|
|||||
|
2019
Q2 | $376M | Buy |
|
|||||
|
2019
Q1 | $230M | Sell |
|
|||||
|
2018
Q4 | $425M | Buy |
|
|||||
|
2018
Q3 | $409M | Sell |
|
|||||
|
2018
Q2 | $479M | Sell |
|
|||||
|
2018
Q1 | $574M | Sell |
|
|||||
|
2017
Q4 | $675M | Buy |
|
|||||
|
2017
Q3 | $593M | Buy |
|
|||||
|
2017
Q2 | $416M | Buy |
|
|||||
|
2017
Q1 | $359M | Sell |
|
|||||
|
2016
Q4 | $395M | Sell |
|
|||||
|
2016
Q3 | $415M | Buy |
|
|||||
|
2016
Q2 | $399M | Sell |
|
|||||
|
2016
Q1 | $448M | Sell |
|
|||||
|
2015
Q4 | $528M | Sell |
|
|||||
|
2015
Q3 | $758M | Sell |
|
|||||
|
2015
Q2 | $1.67B | Buy |
|
|||||
|
2015
Q1 | $1.09B | Buy |
|
|||||
|
2014
Q4 | $1.03B | Sell |
|
|||||
|
2014
Q3 | $928M | Buy |
|
|||||
|
2014
Q2 | $672M | Buy |
|
|||||
|
2014
Q1 | $464M | Sell |
|
|||||
|
2013
Q4 | $737M | Sell |
|
|||||
|
2013
Q3 | $633M | Buy |
|
|||||
|
2013
Q2 | $498M | Buy |
|